Heilongjiang ZBD Pharmaceutical Secures Approval for Chemical Raw Material Drug Listing

MT NewswiresDec 17, 2024 03:44 ET

ZBD Pharma Gets China Approval for Antibacterial Injection

MT NewswiresDec 3, 2024 02:59 ET

Heilongjiang ZBD Pharmaceutical Co., Ltd.'s (SHSE:603567) Stock Price Dropped 3.8% Last Week; Private Equity Firms Would Not Be Happy

Simply Wall StNov 18, 2024 22:22 ET

Report for the third quarter of 2024 of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

SZSIOct 29, 2024 12:00 ET · Announcements

While Shareholders of Heilongjiang ZBD Pharmaceutical (SHSE:603567) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown

Simply Wall StOct 25, 2024 00:39 ET

We Think Heilongjiang ZBD Pharmaceutical (SHSE:603567) Can Stay On Top Of Its Debt

Simply Wall StOct 3, 2024 23:52 ET